Newsletter
Published: 1 Sep 2025, 21:30 IST — Updated: 6 Sep 2025, 12:12 IST

– FDA approves updated Covid boosters, revokes emergency use authorizations.
– Changes may limit vaccine access for children under 5.
– Robert F. Kennedy Jr. announces policy shift on social media.

The Food and Drug Administration (FDA) has approved updated Covid-19 boosters while simultaneously revoking emergency use authorizations for the vaccines. This decision, announced on Wednesday, could potentially make it more challenging for children under the age of five to access these vaccines. The FDA’s move marks a significant shift in the regulatory landscape for Covid-19 vaccinations.

The announcement was made by Robert F. Kennedy Jr., the Secretary of Health and Human Services, through a post on the social media platform X. The FDA itself did not release an official statement regarding the changes. Kennedy emphasized that these actions align with his campaign promises to reverse certain Covid-era policies while ensuring that vaccines remain accessible to those who need them, particularly vulnerable populations.

Kennedy outlined four key promises in his announcement: ending Covid vaccine mandates, maintaining vaccine availability for those who want them, demanding placebo-controlled trials from pharmaceutical companies, and ending the state of emergency. These policy changes reflect a broader strategy to transition away from emergency measures while still prioritizing public health needs.

The revocation of emergency use authorizations could have implications for vaccine distribution, particularly for young children. With the removal of these authorizations, the process for obtaining vaccines may become more complex, potentially affecting availability and access. This development is particularly relevant as public health officials continue to navigate the ongoing challenges posed by Covid-19.

Overall, the FDA’s decision represents a pivotal moment in the management of Covid-19 vaccinations in the United States. As the regulatory framework evolves, stakeholders will need to adapt to ensure that vaccines remain accessible to those who need them most.